Hemo Organic Ltd — Important, 17-02-2026: Company Update

Hemo Organic Limited has received in-principle approval from BSE to issue 99,75,000 convertible warrants. These warrants are convertible into equity shares of Rs. 10 each, at a price of not less than Rs. 12.50 per warrant. The issuance is planned for non-promoters on a preferential basis. This approval is a crucial step for the company to raise capital, potentially funding its operations and future growth. The company must ensure full compliance with all applicable regulations throughout the issuance process and for the subsequent listing of these securities.